2
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A snapshot of protein trafficking in SARS‐CoV‐2 infection

      review-article
      1 , , 1 , 2 , 3 ,
      Biology of the Cell
      John Wiley and Sons Inc.

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          SARS‐CoV‐2 is a human pathogenic virus responsible for the COVID‐19 (coronavirus disease 2019) pandemic. The infection cycle of SARS‐CoV‐2 involves several related steps, including virus entry, gene expression, RNA replication, assembly of infectious virions and their egress. For all of these steps, the virus relies on and exploits host cell factors, cellular organelles, and processes such as endocytosis, nuclear transport, protein secretion, metabolite transport at membrane contact sites (MSC) and exocytotic pathways. To do this, SARS‐CoV‐2 has evolved multifunctional viral proteins that hijack cellular factors and modulate their function by unique strategies. In this Review, we highlight cellular trafficking factors, processes, and organelles of relevance to the SARS‐CoV‐2 infection cycle and how viral proteins make use of and perturb cellular transport during the viral infection cycle.

          Abstract

          The replication of SARS‐CoV‐2 in host cells is influenced by cellular proteins, organelles and processes. Viral proteins efficiently modulate host factors and principles that govern endocytosis, nuclear transport, cytoplasmic trafficking of proteins and metabolites, membrane contact sites (MSC) and exocytotic pathways. This review discusses the examples of viral and host factor interactions affecting these processes.

          Related collections

          Most cited references120

          • Record: found
          • Abstract: found
          • Article: not found

          SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

          Summary The recent emergence of the novel, pathogenic SARS-coronavirus 2 (SARS-CoV-2) in China and its rapid national and international spread pose a global health emergency. Cell entry of coronaviruses depends on binding of the viral spike (S) proteins to cellular receptors and on S protein priming by host cell proteases. Unravelling which cellular factors are used by SARS-CoV-2 for entry might provide insights into viral transmission and reveal therapeutic targets. Here, we demonstrate that SARS-CoV-2 uses the SARS-CoV receptor ACE2 for entry and the serine protease TMPRSS2 for S protein priming. A TMPRSS2 inhibitor approved for clinical use blocked entry and might constitute a treatment option. Finally, we show that the sera from convalescent SARS patients cross-neutralized SARS-2-S-driven entry. Our results reveal important commonalities between SARS-CoV-2 and SARS-CoV infection and identify a potential target for antiviral intervention.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

            Structure of the nCoV trimeric spike The World Health Organization has declared the outbreak of a novel coronavirus (2019-nCoV) to be a public health emergency of international concern. The virus binds to host cells through its trimeric spike glycoprotein, making this protein a key target for potential therapies and diagnostics. Wrapp et al. determined a 3.5-angstrom-resolution structure of the 2019-nCoV trimeric spike protein by cryo–electron microscopy. Using biophysical assays, the authors show that this protein binds at least 10 times more tightly than the corresponding spike protein of severe acute respiratory syndrome (SARS)–CoV to their common host cell receptor. They also tested three antibodies known to bind to the SARS-CoV spike protein but did not detect binding to the 2019-nCoV spike protein. These studies provide valuable information to guide the development of medical counter-measures for 2019-nCoV. Science, this issue p. 1260
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

              Summary The emergence of SARS-CoV-2 has resulted in >90,000 infections and >3,000 deaths. Coronavirus spike (S) glycoproteins promote entry into cells and are the main target of antibodies. We show that SARS-CoV-2 S uses ACE2 to enter cells and that the receptor-binding domains of SARS-CoV-2 S and SARS-CoV S bind with similar affinities to human ACE2, correlating with the efficient spread of SARS-CoV-2 among humans. We found that the SARS-CoV-2 S glycoprotein harbors a furin cleavage site at the boundary between the S1/S2 subunits, which is processed during biogenesis and sets this virus apart from SARS-CoV and SARS-related CoVs. We determined cryo-EM structures of the SARS-CoV-2 S ectodomain trimer, providing a blueprint for the design of vaccines and inhibitors of viral entry. Finally, we demonstrate that SARS-CoV S murine polyclonal antibodies potently inhibited SARS-CoV-2 S mediated entry into cells, indicating that cross-neutralizing antibodies targeting conserved S epitopes can be elicited upon vaccination.
                Bookmark

                Author and article information

                Contributors
                vibhu.prasad@med.uni-heidelberg.de
                ralf.bartenschlager@med.uni-heidelberg.de
                Journal
                Biol Cell
                Biol Cell
                10.1111/(ISSN)1768-322X
                BOC
                Biology of the Cell
                John Wiley and Sons Inc. (Hoboken )
                0248-4900
                1768-322X
                14 November 2022
                14 November 2022
                : 10.1111/boc.202200073
                Affiliations
                [ 1 ] Department of Infectious Diseases Molecular Virology Heidelberg University Heidelberg Germany
                [ 2 ] Division Virus‐Associated Carcinogenesis German Cancer Research Center Heidelberg Germany
                [ 3 ] German Center for Infection Research Heidelberg Partner Site Heidelberg Germany
                Author notes
                [*] [* ] Correspondence

                Vibhu Prasad, Department of Infectious Diseases, Molecular Virology, Heidelberg University, Heidelberg, Germany.

                Email: vibhu.prasad@ 123456med.uni-heidelberg.de

                Ralf Bartenschlager, German Center for Infection Research, Heidelberg Partner Site, Heidelberg, Germany.

                Email: ralf.bartenschlager@ 123456med.uni-heidelberg.de

                Author information
                https://orcid.org/0000-0001-7450-607X
                https://orcid.org/0000-0001-5601-9307
                Article
                BOC202200073
                10.1111/boc.202200073
                9874443
                36314261
                2613cf2f-bdef-4c55-bec9-218705ca930c
                © 2021 The Authors. Biology of the Cell published by Wiley‐VCH GmbH on behalf of Société Française des Microscopies and Société de Biologie Cellulaire de France

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

                History
                : 27 September 2022
                : 01 August 2022
                : 13 October 2022
                Page count
                Figures: 6, Tables: 0, Pages: 16, Words: 10595
                Categories
                Review
                Review
                Custom metadata
                2.0
                corrected-proof
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.2.3 mode:remove_FC converted:25.01.2023

                Cell biology
                Cell biology

                Comments

                Comment on this article